Epithelial and neuroendocrine pancreatic tumors, while distinct in their morphological and genetic profiles, share common pathogenic mechanisms, including BRCA1 and BRCA2 gene mutations, impaired p53 function, and HIF-2α and mTOR receptor alterations. This evidence concerns the gene BRCA1 and pancreatic neuroendocrine tumor.